The Global Development Medical Director in Late Phase Cardiovascular, Renal, and Metabolic diseases (CVRM) provides medical and scientific leadership for clinical trials, with a focus on cardiovascular/renal or metabolic dysfunction, including diabetes, obesity, and NASH/MASH. The role is responsible for the design, conduct, monitoring, data interpretation, and reporting of individual trials, ensuring that the study data can establish the compound’s benefits and risks and support the intended label indication and pricing in markets globally. The position operates in accordance with internal SOPs, local regulations and laws, Good Clinical Practice, and regulatory requirements. The role provides medical and scientific input throughout the study lifecycle; delivers medical information and responses to regulators, ethics committees, marketing companies, investigators, and sites; and is accountable to the Global Clinical Head for study medical aspects and design. In collaboration with the study team, the director drives decisions, resolves medical issues, and oversees medical and ethical study components, including patient safety. The director delivers key study documents, conducts study-level safety surveillance, supports investigator meetings and national activities, and works with the Global Clinical Head to approve Clinical Study Reports. The role also maintains awareness of emerging medical developments and applies strategic judgment in work with alliance partners, regulators, payers, opinion leaders, prescribers, consumers, and regional marketing companies.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree